[1]
Z. Al-Mashhadani and I. S. Arif, “Adapting Hydralazine as a Reliable Low-Toxicity Alternative to Cobalt Chloride for Hypoxia Modeling in Breast Cancer Cells”, Al-Rafidain J Med Sci, vol. 10, no. 2, pp. 171–176, Apr. 2026.